New modality of dialysis therapy: peritoneal dialysis first and transition to home hemodialysis.

Hiromichi Suzuki, Hitosi Hoshi, Tsutomu Inoue, Tomohiro Kikuta, Masahiro Tsuda, Tsuneo Takenaka
{"title":"New modality of dialysis therapy: peritoneal dialysis first and transition to home hemodialysis.","authors":"Hiromichi Suzuki,&nbsp;Hitosi Hoshi,&nbsp;Tsutomu Inoue,&nbsp;Tomohiro Kikuta,&nbsp;Masahiro Tsuda,&nbsp;Tsuneo Takenaka","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Recent studies have clearly demonstrated that start ing treatment with peritoneal dialysis (PD) is superior to starting with conventional hemodialysis (HD) because PD preserves residual renal function for a longer period. Similarly, because of the frequency of treatments, home HD (HHD) is also superior to conventional HD. The accumulated evidence suggests that a combination of PD and HHD might be a new and effective method for patients receiving dialysis therapy. We analyzed 10 patients who, over the past 10 years, were started on PD and who were then transferred to HHD. Electronic databases were used to examine changes in their health status. Mean age was 58 +/- 8 years in these 2 female and 8 male patients. Mean duration of PD was 6.9 +/- 2.4 years. The average total duration of dialysis therapy was 9.7 +/- 1.9 years. The main reason for the transition from PD to HHD was loss of residual renal function. To the time of writing, no serious complications (including cardiovascular events and calcium homeostasis) had occurred. All patients continue to receive dialysis therapy and have been able to lead a nearly normal social life. Major laboratory findings include serum albumin 4.2 +/- 0.2 g/dL, hemoglobin 10.2 +/- 1.4 g/dL (half the patients were not using erythropoiesis-stimulating agents), serum creatinine 7.5 +/- 2.5 mg/dL, blood urea nitrogen 36 +/- 17 mg/dL, serum phosphate 4.3 mg/dL. In two thirds of the patients, blood pressure was controlled without antihypertensive agents. No patient had left ventricular hypertrophy. In this analysis, we found that relatively young subjects preferred PD first, with later transfer to HHD; that PD is superior as an introduction to dialysis therapy; that patients starting with PD prefer self medical treatment; and that all patients were free from the various complications that are encountered during long-term dialysis therapy. We suggest that patients who need dialysis therapy consider this new dialysis approach of \"PD first and transfer to HHD.\"</p>","PeriodicalId":7361,"journal":{"name":"Advances in peritoneal dialysis. Conference on Peritoneal Dialysis","volume":"28 ","pages":"106-11"},"PeriodicalIF":0.0000,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in peritoneal dialysis. Conference on Peritoneal Dialysis","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Recent studies have clearly demonstrated that start ing treatment with peritoneal dialysis (PD) is superior to starting with conventional hemodialysis (HD) because PD preserves residual renal function for a longer period. Similarly, because of the frequency of treatments, home HD (HHD) is also superior to conventional HD. The accumulated evidence suggests that a combination of PD and HHD might be a new and effective method for patients receiving dialysis therapy. We analyzed 10 patients who, over the past 10 years, were started on PD and who were then transferred to HHD. Electronic databases were used to examine changes in their health status. Mean age was 58 +/- 8 years in these 2 female and 8 male patients. Mean duration of PD was 6.9 +/- 2.4 years. The average total duration of dialysis therapy was 9.7 +/- 1.9 years. The main reason for the transition from PD to HHD was loss of residual renal function. To the time of writing, no serious complications (including cardiovascular events and calcium homeostasis) had occurred. All patients continue to receive dialysis therapy and have been able to lead a nearly normal social life. Major laboratory findings include serum albumin 4.2 +/- 0.2 g/dL, hemoglobin 10.2 +/- 1.4 g/dL (half the patients were not using erythropoiesis-stimulating agents), serum creatinine 7.5 +/- 2.5 mg/dL, blood urea nitrogen 36 +/- 17 mg/dL, serum phosphate 4.3 mg/dL. In two thirds of the patients, blood pressure was controlled without antihypertensive agents. No patient had left ventricular hypertrophy. In this analysis, we found that relatively young subjects preferred PD first, with later transfer to HHD; that PD is superior as an introduction to dialysis therapy; that patients starting with PD prefer self medical treatment; and that all patients were free from the various complications that are encountered during long-term dialysis therapy. We suggest that patients who need dialysis therapy consider this new dialysis approach of "PD first and transfer to HHD."

新的透析治疗方式:腹膜透析为主,过渡到家庭血液透析。
最近的研究清楚地表明,开始使用腹膜透析(PD)治疗优于开始使用传统血液透析(HD)治疗,因为PD可以在更长的时间内保留剩余的肾功能。同样,由于治疗的频率,家庭高清(HHD)也优于传统高清。越来越多的证据表明,PD与HHD联合治疗可能是一种新的、有效的透析治疗方法。我们分析了10名患者,在过去的10年里,他们开始接受PD治疗,然后转移到HHD。使用电子数据库来检查他们健康状况的变化。女性2例,男性8例,平均年龄58±8岁。PD的平均持续时间为6.9±2.4年。透析治疗的平均总持续时间为9.7±1.9年。从PD过渡到HHD的主要原因是残余肾功能的丧失。截至撰写本文时,未发生严重并发症(包括心血管事件和钙稳态)。所有患者都继续接受透析治疗,并能过上几乎正常的社交生活。主要实验室检查结果:血清白蛋白4.2 +/- 0.2 g/dL,血红蛋白10.2 +/- 1.4 g/dL(半数患者未使用促红细胞生成素),血清肌酐7.5 +/- 2.5 mg/dL,血尿素氮36 +/- 17 mg/dL,血清磷酸盐4.3 mg/dL。在三分之二的患者中,血压在不使用降压药的情况下得到控制。无左心室肥厚。在本分析中,我们发现相对年轻的受试者首先倾向于PD,随后转移到HHD;PD是透析治疗的首选;PD患者倾向于自我治疗;所有患者都没有长期透析治疗中遇到的各种并发症。我们建议需要透析治疗的患者考虑这种“先PD后HHD”的新透析方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信